You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clonal evolution

Showing 1 - 25 of 2,696
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GATA2 Gene Mutation Trial in France (Biological samples (blood and bone marrow samples).)

Not yet recruiting
  • GATA2 Gene Mutation
  • Biological samples (blood and bone marrow samples).
  • Angers, France
  • +16 more
Jul 31, 2023

MRD and Clonal Evolution in Waldenström's Macroglobulinemia and

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • MRD and clonal evolution
  • Milano, MI, Italy
  • +13 more
Nov 2, 2022

Severe Aplastic Anemia Who Developed High Risk Clonal Evolution

Completed
  • Severe Aplastic Anemia
    • Bethesda, Maryland
      National Heart, Lung and Blood Institute (NHLBI)
    Apr 7, 2022

    ctDNA Methylation Sequencing for Myeloma

    Recruiting
    • Multiple Myeloma
    • plasma circulation DNA methylation sequencing
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    Oct 11, 2022

    Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

    Recruiting
    • Lung Neoplasms
    • +3 more
    • Observation
    • Shanghai, China
      Shanghai Chest Hospital
    Mar 14, 2022

    Primary Liver Cancer, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in China (Observation)

    Recruiting
    • Primary Liver Cancer
    • +3 more
    • Observation
    • Beijing, Beijing, China
    • +4 more
    Jun 14, 2022

    Multiple Myeloma Trial in La Roche-sur-Yon, Nantes (No interventional study)

    Recruiting
    • Multiple Myeloma
    • No interventional study
    • La Roche-sur-Yon, France
    • +1 more
    Aug 5, 2021

    Bladder Cancer Trial in United States (Abemaciclib)

    Recruiting
    • Bladder Cancer
    • Tampa, Florida
    • +3 more
    Jul 27, 2022

    In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies

    Recruiting
    • Prostate Cancer
    • Genetic Predisposition
    • clonal heterogeneity evaluation
    • Lugano, Ticino, Switzerland
      Alessandra Franzetti Pellanda
    Jul 19, 2022

    Dynamics of Clonal Evolution Leading to Recurrence in Prostate

    Recruiting
    • Prostate Cancer Recurrent
      • Sutton, Surrey, United Kingdom
        Royal Marsden Hospital
      Dec 22, 2020

      Ovarian Cancer Trial in Vandœuvre-lès-Nancy (Diagnostic Test)

      Recruiting
      • Ovarian Cancer
      • Diagnostic Test
      • Vandœuvre-lès-Nancy, France
        Institut de Cancerologie de Lorraine
      Mar 29, 2022

      Cancer for Patients Undergoing Transoral Robotic Surgery for

      Recruiting
      • Head & Neck Squamous Cell Cancer (HNSCC)
      • DNA Analysis
      • London, United Kingdom
        The Royal Marsden Hospital
      Dec 16, 2020

      Metastatic Oncogen-driven Cancer Trial in Villejuif (Biopsy)

      Recruiting
      • Metastatic Oncogen-driven Cancer
      • Biopsy
      • Villejuif, Val De Marne, France
        Gustave Roussy Cancer Campus Grand Paris
      Feb 23, 2021

      Assessed With Liquid Biopsy of NSCLC Patients in China

      Completed
      • Lung Neoplasms
      • +3 more
        • Guangzhou, Guangdong, China
        • +13 more
        Feb 3, 2020

        B Cells in High-risk CLL After Idelalisib-rituximab

        Withdrawn
        • Chronic Lymphocytic Leukemia
        • Biospecimen Collection
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Apr 12, 2019

        Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

        Not yet recruiting
        • Myeloproliferative Neoplasm
        • Secondary Leukemia
        • Multiomic characterization
        • In vitro drug screening
        • (no location specified)
        Aug 28, 2023

        Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood

        Not yet recruiting
        • Severe Aplastic Anemia
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 23, 2023

        Steroid-refractory Diamond-Blackfan Anemia (DBA) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Bitopertin)

        Not yet recruiting
        • Steroid-refractory Diamond-Blackfan Anemia (DBA)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Apr 28, 2023

        Aplastic Anemia Trial in Beijing (Avatrombopag+CsA)

        Not yet recruiting
        • Aplastic Anemia
        • Beijing, China
          Peking union medical college hospital
        Aug 16, 2023

        Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)

        Recruiting
        • Severe Aplastic Anemia
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 27, 2023

        Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC

        Recruiting
        • Non-small Cell Lung Cancer
          • Guanzhou, China
            Sun Yat-sen University Cancer Center
          Aug 11, 2023

          Genomic Evolution of Metastasis in Gastric Cancer

          Recruiting
          • Gastric Cancer
          • Metastasis
            • Ho Chi Minh City, Vietnam
              University Medical Center Ho Chi Minh City
            Apr 27, 2022

            Non Small Cell Lung Cancer, EGFR Gene Mutation, Immune Checkpoint Inhibitor Trial in Jerusalem (concomitant TTFields treatment

            Not yet recruiting
            • Non Small Cell Lung Cancer
            • +2 more
            • concomitant TTFields treatment device to standard of care EGFR positive NSCLC treatment
            • concomitant TTFields treatment device to standard of care anti PD-1 NSCLC treatment
            • Jerusalem, Israel
              Shaare Zedek Medical Center
            Jan 22, 2023

            Shwachman-Diamond Syndrome, Shwachman-Diamond Syndrome-Like Trial in Aurora, Boston, Cincinnati

            Recruiting
            • Shwachman-Diamond Syndrome
            • Shwachman-Diamond Syndrome-Like
              • Aurora, Colorado
              • +3 more
              Sep 25, 2023

              Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving

              Recruiting
              • Non-small Cell Lung Cancer
              • Oligometastatic Disease
              • ctDNA testing and whole exome sequencing
              • Guangzhou, Guangdong, China
                Guangdong Lung Cancer Institute, Guangdong Provincial People's H
              Dec 5, 2022